• About Us
    • Company
    • Chairman’s Message
    • Team
    • Course
    • Corporate Culture
    • Honour
  • Technology
    • Research and Develop
    • Innovation Platform
    • Innovative Drugs
    • Research and Development Pipeline
  • Product
    • Digestive System
    • Cardiovascular System
    • Endocrine System
    • Nervous System
    • Inflammation
    • Respiratory System
  • News
    • Company News
    • Media Coverage
  • Investor
    • Announcements and Circulars
    • Financial Reports
    • Prospectus
    • Corporate Governance
    • Contact
  • Attract Talents
    • Talent Development
    • Recruitment Position
  • Contact Us
    • Contact Us
    • Product Consultation
  • En
    • 中文
    • 繁体
    • EN
  • 中文
  • 繁体
  • EN
  • About Us
  • Company
  • Chairman’s Message
  • Team
  • Course
  • Corporate Culture
  • Honour
  • Technology
  • Research and Develop
  • Innovation Platform
  • Innovative Drugs
  • Research and Development Pipeline
  • Product
  • Digestive System
  • Cardiovascular System
  • Endocrine System
  • Nervous System
  • Inflammation
  • Respiratory System
  • News
  • Company News
  • Media Coverage
  • Investor
  • Announcements and Circulars
  • Financial Reports
  • Prospectus
  • Corporate Governance
  • Contact
  • Attract Talents
  • Talent Development
  • Recruitment Position
  • Contact Us
  • Contact Us
  • Product Consultation
Investor
  1. Home
  2. Investor
  3. Announcements and Circulars
Announcements and Circulars Financial Reports Prospectus Corporate Governance Contact
  • 2026
  • 2025
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026
2026-04-08
Download
Company Profile of Haixi Pharmaceutical
2026-04-03
Download
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025
2026-03-30
Download
自願公告 - wAMD口服藥物項目HXP056完成一期臨床研究招募並啟動二期研究
2026-03-24
Download
DATE OF MEETING OF THE BOARD OF DIRECTORS
2026-03-10
Download
CHANGE OF JOINT COMPANY SECRETARY, AUTHORISED REPRESENTATIVES AND PROCESS AGENT AND WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES
2026-03-06
Download
About Us
Technology
Product
News
Investor
Attract Talents
Contact Us

Fujian Haixi New Pharmaceutical Creation Co., Ltd. Fujian ICP Record No. 12015727 Internet Drug Information Service Qualification Certificate No.: (Min) - Non-operating-2023-0063

Some of the text and pictures on this site are from the Internet and are only used for sharing and learning. If your rights and interests are infringed, please inform us in time, and this site will deal with or replace them in time.